The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGSS.L Regulatory News (GSS)

  • There is currently no data for GSS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Edison update on Genesis Emerging Markets Fund

8 Jun 2021 07:00

RNS Number : 0161B
Genesis Emerging Markets Fund Ld
08 June 2021
 

 

London, UK, 8 June 2021

 

Edison issues update on Genesis Emerging Markets Fund (GSS)

Genesis Emerging Markets Fund (GSS) continues to benefit from diversification across a range of sectors and countries. It has performed competitively in the ongoing recovery and is well positioned to take advantage of a further broad-based recovery in emerging markets (EMs). Genesis has a real impact on investee companies, by actively engaging with them. At Genesis, the asset management group, portfolio managers (PMs) engage with companies directly, thus allowing constructive dialogue with them. The company considers this to be one of the key differentiators for the fund. As an active investor, Genesis regards proxy voting as one of the key stewardship tools to support, influence and challenge portfolio companies' decisions. ESG considerations directly affect portfolio outcomes as they are a key determinant of the sizing of individual investments in the portfolio.

 

GSS's key objective is to protect and grow long-term shareholder value, which it has achieved over the medium and long term. The trust's NAV returned 89% over 10 years. The chart above illustrates GSS's NAV outperforming (above the 100 grey baseline) the MSCI Emerging Markets Index over a three-year period on a total return basis. EM is the firm's only asset class and all its resources are deployed towards managing EM equities, which is one of GSS's differentiating features. The other key feature is Genesis's in-house approach to environmental, social and corporate governance (ESG), which we discuss in this report.

Click here to view the full report or here to sign up to receive research as it is published.

 

All reports published by Edison are available to download free of charge from its website

www.edisongroup.com

About Edison: Edison is a leading research and investor relations consultancy, connecting listed companies to the widest pool of global investors. By focusing on the volume and quality of investors reached - across institutions, family offices, wealth managers and retail investors - Edison can create and gauge intent to purchase, even in the darkest pools of capital, and then make introductions via non-deal roadshows, events or virtual meetings.

Having been the first in-market 17 years ago, Edison now has more than 100 analysts covering every economic sector. Headquartered in London, Edison also has offices in New York, Frankfurt, Amsterdam and Tel Aviv and a presence in Athens, Johannesburg and Sydney.

Edison is authorised and regulated by the Financial Conduct Authority.

Edison is not an adviser or broker-dealer and does not provide investment advice. Edison's reports are not solicitations to buy or sell any securities.

For more information, please contact Edison:

Victoria Chernykh +44 (0)20 3077 5700 investmenttrusts@edisongroup.com

Sarah Godfrey +44 (0)20 3681 2519 investmenttrusts@edisongroup.com

Learn more at www.edisongroup.com and connect with Edison on:

LinkedIn www.linkedin.com/company/edison-group-/

Twitter www.twitter.com/Edison_Inv_Res 

YouTube www.youtube.com/edisonitv

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRADKOBNFBKKDAK
Date   Source Headline
3rd Jun 202111:06 amRNSNet Asset Value(s)
2nd Jun 202111:11 amRNSNet Asset Value(s)
1st Jun 202112:42 pmRNSNet Asset Value(s)
28th May 20215:29 pmRNSTotal Voting Rights
28th May 202110:09 amRNSNet Asset Value(s)
27th May 202110:19 amRNSNet Asset Value(s)
26th May 202110:41 amRNSNet Asset Value(s)
25th May 202111:23 amRNSNet Asset Value(s)
24th May 202111:03 amRNSNet Asset Value(s)
21st May 202110:29 amRNSNet Asset Value(s)
20th May 202110:26 amRNSNet Asset Value(s)
19th May 202110:15 amRNSNet Asset Value(s)
18th May 202110:40 amRNSNet Asset Value(s)
17th May 20214:32 pmRNSAvailability of Monthly Factsheet
17th May 202110:28 amRNSNet Asset Value(s)
14th May 202110:56 amRNSNet Asset Value(s)
13th May 202110:13 amRNSNet Asset Value(s)
12th May 202111:04 amRNSNet Asset Value(s)
11th May 202110:37 amRNSNet Asset Value(s)
10th May 202110:30 amRNSNet Asset Value(s)
7th May 202110:14 amRNSNet Asset Value(s)
6th May 202110:35 amRNSNet Asset Value(s)
5th May 202110:28 amRNSNet Asset Value(s)
4th May 20211:26 pmRNSNet Asset Value(s)
30th Apr 20215:32 pmRNSTotal Voting Rights
30th Apr 202110:25 amRNSNet Asset Value(s)
29th Apr 202110:13 amRNSNet Asset Value(s)
28th Apr 202110:47 amRNSNet Asset Value(s)
27th Apr 202110:46 amRNSNet Asset Value(s)
26th Apr 202111:18 amRNSNet Asset Value(s)
23rd Apr 202111:08 amRNSNet Asset Value(s)
22nd Apr 202112:23 pmRNSNet Asset Value(s)
21st Apr 202111:06 amRNSNet Asset Value(s)
20th Apr 202110:21 amRNSNet Asset Value(s)
19th Apr 202110:44 amRNSNet Asset Value(s)
16th Apr 20215:36 pmRNSAvailability of Monthly Factsheet
16th Apr 20215:35 pmRNSAvailability of Quarterly Update
16th Apr 202111:04 amRNSNet Asset Value(s)
15th Apr 202110:55 amRNSNet Asset Value(s)
14th Apr 202110:45 amRNSNet Asset Value(s)
13th Apr 202110:25 amRNSNet Asset Value(s)
12th Apr 202111:24 amRNSNet Asset Value(s)
9th Apr 202110:59 amRNSNet Asset Value(s)
8th Apr 202112:07 pmRNSAvailability of Quarterly Shareholder Letter
8th Apr 202111:08 amRNSNet Asset Value(s)
7th Apr 202110:46 amRNSNet Asset Value(s)
6th Apr 202110:41 amRNSNet Asset Value(s)
1st Apr 202112:34 pmRNSNet Asset Value(s)
31st Mar 20215:51 pmRNSTotal Voting Rights
31st Mar 202110:41 amRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.